ReP USP - Resultado da busca

Artigo de periodico
A serum-based DNA methylation assay provides accurate detection of glioma (2021)
Sabedot, Thais S; Malta, Tathiane M; Snyder, James; Nelson, Kevin; Wells, Michael; Carvalho, Ana C. de; Mukherjee, Abir; Chitale, Dhananjay A; Mosella, Maritza S; Sokolov, Artem; Asmaro, Karam P; Robin, Adam; Rosenblum, Mark L; Mikkelsen, Tom; Rock, Jack; Poisson, Laila M; Lee, Ian; Walbert, Tobias; Kalkanis, Steven; Iavarone, Antonio; Castro, Ana Valeria; Noushmehr, Houtan
Fonte: Neuro-Oncology. Unidade: FMRP
Assuntos: BIOMARCADORES, GLIOMA, NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, EPIGÊNESE GENÉTICA, BIÓPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais S et al. A serum-based DNA methylation assay provides accurate detection of glioma. Neuro-Oncology, v. 23, n. 9, p. 1494-1508, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab023. Acesso em: 23 out. 2025.
APA
Sabedot, T. S., Malta, T. M., Snyder, J., Nelson, K., Wells, M., Carvalho, A. C. de, et al. (2021). A serum-based DNA methylation assay provides accurate detection of glioma. Neuro-Oncology, 23( 9), 1494-1508. doi:10.1093/neuonc/noab023
NLM
Sabedot TS, Malta TM, Snyder J, Nelson K, Wells M, Carvalho AC de, Mukherjee A, Chitale DA, Mosella MS, Sokolov A, Asmaro KP, Robin A, Rosenblum ML, Mikkelsen T, Rock J, Poisson LM, Lee I, Walbert T, Kalkanis S, Iavarone A, Castro AV, Noushmehr H. A serum-based DNA methylation assay provides accurate detection of glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1494-1508.[citado 2025 out. 23 ] Available from: https://doi.org/10.1093/neuonc/noab023
Vancouver
Sabedot TS, Malta TM, Snyder J, Nelson K, Wells M, Carvalho AC de, Mukherjee A, Chitale DA, Mosella MS, Sokolov A, Asmaro KP, Robin A, Rosenblum ML, Mikkelsen T, Rock J, Poisson LM, Lee I, Walbert T, Kalkanis S, Iavarone A, Castro AV, Noushmehr H. A serum-based DNA methylation assay provides accurate detection of glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1494-1508.[citado 2025 out. 23 ] Available from: https://doi.org/10.1093/neuonc/noab023
Trabalho de evento-resumo periodico
DNA methylation-based liquid biopsy detects primary and recurrent meningioma (2020)
Sabedot, Thais Sarraf; Malta, Tathiane M.; Snyder, James; Walbert, Tobias; Lee, Ian; Kalkanis, Steven; Castro, Ana Valéria; Noushmehr, Houtan
Fonte: Clinical Cancer Research. Nome do evento: AACR Special Conference on Advances in Liquid Biopsies. Unidade: FMRP
Assuntos: BIÓPSIA, METILAÇÃO DE DNA, MENINGIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais Sarraf et al. DNA methylation-based liquid biopsy detects primary and recurrent meningioma. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1557-3265.LiqBiop20-A12. Acesso em: 23 out. 2025. , 2020
APA
Sabedot, T. S., Malta, T. M., Snyder, J., Walbert, T., Lee, I., Kalkanis, S., et al. (2020). DNA methylation-based liquid biopsy detects primary and recurrent meningioma. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1557-3265.LiqBiop20-A12
NLM
Sabedot TS, Malta TM, Snyder J, Walbert T, Lee I, Kalkanis S, Castro AV, Noushmehr H. DNA methylation-based liquid biopsy detects primary and recurrent meningioma [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2025 out. 23 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A12
Vancouver
Sabedot TS, Malta TM, Snyder J, Walbert T, Lee I, Kalkanis S, Castro AV, Noushmehr H. DNA methylation-based liquid biopsy detects primary and recurrent meningioma [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2025 out. 23 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A12
Trabalho de evento-resumo periodico
DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas (2019)
Wells, Michael; Sabedot, Thais Sarraf; Asmaro, Karam; Mosella, Maritza Queiroz Salas ; Malta, Tathiane; Nelson, Kevin; Snyder, James; Carvalho, Ana de; Mukherjee, Abir; Bahn, Arti; Robin, Adam; Rosenblum, Mark; Mikkelsen, Tom; Poisson, Laila; Lee, Ian; Walbert, Tobias; Kalkanis, Steven; Rock, Jack; Noushmehr, Houtan ; Chitale, Dhananjay; Castro, Anavaleria
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS, GLÂNDULA PITUITÁRIA, METILAÇÃO DE DNA, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WELLS, Michael et al. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.426. Acesso em: 23 out. 2025. , 2019
APA
Wells, M., Sabedot, T. S., Asmaro, K., Mosella, M. Q. S., Malta, T., Nelson, K., et al. (2019). DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.426
NLM
Wells M, Sabedot TS, Asmaro K, Mosella MQS, Malta T, Nelson K, Snyder J, Carvalho A de, Mukherjee A, Bahn A, Robin A, Rosenblum M, Mikkelsen T, Poisson L, Lee I, Walbert T, Kalkanis S, Rock J, Noushmehr H, Chitale D, Castro A. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas [Internet]. Neuro-oncology. 2019 ; 21 vi102.[citado 2025 out. 23 ] Available from: https://doi.org/10.1093/neuonc/noz175.426
Vancouver
Wells M, Sabedot TS, Asmaro K, Mosella MQS, Malta T, Nelson K, Snyder J, Carvalho A de, Mukherjee A, Bahn A, Robin A, Rosenblum M, Mikkelsen T, Poisson L, Lee I, Walbert T, Kalkanis S, Rock J, Noushmehr H, Chitale D, Castro A. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas [Internet]. Neuro-oncology. 2019 ; 21 vi102.[citado 2025 out. 23 ] Available from: https://doi.org/10.1093/neuonc/noz175.426
Trabalho de evento-resumo periodico
Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma (2019)
Lee, Ian; Hunt, Rachel; Nelson, Kevin; Patil, Darshana; Datta, Vineet; Akolkar, Dadasaheb; Apurva, Sachin; Fulmali, Pooja; Puranik, Sneha; Snyder, James; Noushmehr, Houtan ; Devhare, Pradeep; Carvalho, Ana de; Datar, Rajan; Walbert, Tobias; Kalkanis, Steven
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS CEREBRAIS, GLIOMA, LEUCEMIA, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEE, Ian et al. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.659. Acesso em: 23 out. 2025. , 2019
APA
Lee, I., Hunt, R., Nelson, K., Patil, D., Datta, V., Akolkar, D., et al. (2019). Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.659
NLM
Lee I, Hunt R, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, Carvalho A de, Datar R, Walbert T, Kalkanis S. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma [Internet]. Neuro-oncology. 2019 ; 21 vi157–vi158.[citado 2025 out. 23 ] Available from: https://doi.org/10.1093/neuonc/noz175.659
Vancouver
Lee I, Hunt R, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, Carvalho A de, Datar R, Walbert T, Kalkanis S. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma [Internet]. Neuro-oncology. 2019 ; 21 vi157–vi158.[citado 2025 out. 23 ] Available from: https://doi.org/10.1093/neuonc/noz175.659
Trabalho de evento-resumo periodico
Methylation-based liquid biopsy of meningioma primary and recurrent samples (2019)
Sabedot, Thais Sarraf; Malta, Tathiane; Snyder, James; Walbert, Tobias; Lee, Ian; Kalkanis, Steven; Castro, Anavaleria; Noushmehr, Houtan
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: MENINGIOMA, NEOPLASIAS CEREBRAIS, BIÓPSIA, BIOMARCADORES, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais Sarraf et al. Methylation-based liquid biopsy of meningioma primary and recurrent samples. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.463. Acesso em: 23 out. 2025. , 2019
APA
Sabedot, T. S., Malta, T., Snyder, J., Walbert, T., Lee, I., Kalkanis, S., et al. (2019). Methylation-based liquid biopsy of meningioma primary and recurrent samples. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.463
NLM
Sabedot TS, Malta T, Snyder J, Walbert T, Lee I, Kalkanis S, Castro A, Noushmehr H. Methylation-based liquid biopsy of meningioma primary and recurrent samples [Internet]. Neuro-oncology. 2019 ; 21 vi111.[citado 2025 out. 23 ] Available from: https://doi.org/10.1093/neuonc/noz175.463
Vancouver
Sabedot TS, Malta T, Snyder J, Walbert T, Lee I, Kalkanis S, Castro A, Noushmehr H. Methylation-based liquid biopsy of meningioma primary and recurrent samples [Internet]. Neuro-oncology. 2019 ; 21 vi111.[citado 2025 out. 23 ] Available from: https://doi.org/10.1093/neuonc/noz175.463
Trabalho de evento-resumo periodico
Pre-surgical identification of diagnostic, prognostic and predictive DNA methylation-based markers in serum (liquid biopsy) of patients harboring gliomas (2019)
Noushmehr, Houtan ; Sabedot, Thais S.; Malta, Tathiane M.; Nelson, Kevin K.; Snyder, James; Wells, Michael; Mosella, Maritza S.; Carvalho, Ana de; Asmaro, karam; Scarpace, Lisa; Robin, Adam M.; Rosenblum, Mark L.; Mikkelsen, Tom; Rock, Jack; Walbert, Tobias; Lee, Ian; Poisson, Laila M.; Kalkanis, Steven N.; Castro, Ana V.
Fonte: Cancer Research. Nome do evento: Annual Meeting American Association for Cancer Research - AACR. Unidade: FMRP
Assuntos: NEOPLASIAS OVARIANAS, GENÉTICA MÉDICA, TUMOR CARCINOIDE, GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOUSHMEHR, Houtan et al. Pre-surgical identification of diagnostic, prognostic and predictive DNA methylation-based markers in serum (liquid biopsy) of patients harboring gliomas. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2019-LB-234. Acesso em: 23 out. 2025. , 2019
APA
Noushmehr, H., Sabedot, T. S., Malta, T. M., Nelson, K. K., Snyder, J., Wells, M., et al. (2019). Pre-surgical identification of diagnostic, prognostic and predictive DNA methylation-based markers in serum (liquid biopsy) of patients harboring gliomas. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2019-LB-234
NLM
Noushmehr H, Sabedot TS, Malta TM, Nelson KK, Snyder J, Wells M, Mosella MS, Carvalho A de, Asmaro karam, Scarpace L, Robin AM, Rosenblum ML, Mikkelsen T, Rock J, Walbert T, Lee I, Poisson LM, Kalkanis SN, Castro AV. Pre-surgical identification of diagnostic, prognostic and predictive DNA methylation-based markers in serum (liquid biopsy) of patients harboring gliomas [Internet]. Cancer Research. 2019 ; 79( 13): .[citado 2025 out. 23 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-LB-234
Vancouver
Noushmehr H, Sabedot TS, Malta TM, Nelson KK, Snyder J, Wells M, Mosella MS, Carvalho A de, Asmaro karam, Scarpace L, Robin AM, Rosenblum ML, Mikkelsen T, Rock J, Walbert T, Lee I, Poisson LM, Kalkanis SN, Castro AV. Pre-surgical identification of diagnostic, prognostic and predictive DNA methylation-based markers in serum (liquid biopsy) of patients harboring gliomas [Internet]. Cancer Research. 2019 ; 79( 13): .[citado 2025 out. 23 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-LB-234

Unidades USP

ReP

Filtros

Autores

Assuntos

Indexado em

Afiliação dos autores externos não normalizada